nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Estropipate—osteoporosis	0.0693	0.518	CbGbCtD
Capecitabine—CYP2C9—Cholecalciferol—osteoporosis	0.0357	0.267	CbGbCtD
Capecitabine—CYP2C9—Estradiol—osteoporosis	0.0288	0.215	CbGbCtD
Capecitabine—DPYD—Nucleotide metabolism—PNP—osteoporosis	0.00861	0.0593	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—ATIC—osteoporosis	0.00861	0.0593	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—ATIC—osteoporosis	0.00767	0.0528	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—PNP—osteoporosis	0.00767	0.0528	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—ATIC—osteoporosis	0.00712	0.049	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—PNP—osteoporosis	0.00613	0.0422	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—ATIC—osteoporosis	0.00613	0.0422	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00448	0.0308	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00399	0.0275	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00319	0.022	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—ATIC—osteoporosis	0.00314	0.0216	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—PNP—osteoporosis	0.00314	0.0216	CbGpPWpGaD
Capecitabine—TYMS—Levorphanol—Estradiol—osteoporosis	0.00281	0.469	CbGdCrCtD
Capecitabine—TYMS—Circadian rythm related genes—ID4—osteoporosis	0.0028	0.0193	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—GPX1—osteoporosis	0.00244	0.0168	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00235	0.0162	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—GPX1—osteoporosis	0.00217	0.015	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—MTHFR—osteoporosis	0.00186	0.0128	CbGpPWpGaD
Capecitabine—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00186	0.31	CbGdCrCtD
Capecitabine—TYMP—Nucleotide metabolism—GPX1—osteoporosis	0.00174	0.012	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00167	0.0115	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00163	0.0112	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—osteoporosis	0.00155	0.0107	CbGpPWpGaD
Capecitabine—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00133	0.222	CbGdCrCtD
Capecitabine—TYMS—G1/S Transition—PSMA5—osteoporosis	0.00103	0.00709	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—PSMA2—osteoporosis	0.00103	0.00709	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PKM—osteoporosis	0.000902	0.00621	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—FDPS—osteoporosis	0.000902	0.00621	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.000889	0.00612	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000868	0.00597	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000868	0.00597	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PGLS—osteoporosis	0.000855	0.00589	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GPD2—osteoporosis	0.000855	0.00589	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000825	0.00568	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PKM—osteoporosis	0.000804	0.00553	CbGpPWpGaD
Capecitabine—CDA—Metabolism—FDPS—osteoporosis	0.000804	0.00553	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ATIC—osteoporosis	0.000782	0.00538	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PNP—osteoporosis	0.000782	0.00538	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—AGER—osteoporosis	0.000781	0.00538	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GPD2—osteoporosis	0.000762	0.00525	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PGLS—osteoporosis	0.000762	0.00525	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000739	0.00509	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000729	0.00502	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ATIC—osteoporosis	0.000697	0.0048	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PNP—osteoporosis	0.000697	0.0048	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA2—osteoporosis	0.000665	0.00458	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—OXCT1—osteoporosis	0.000665	0.00458	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MGLL—osteoporosis	0.000648	0.00446	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PKM—osteoporosis	0.000643	0.00442	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—FDPS—osteoporosis	0.000643	0.00442	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPD2—osteoporosis	0.000609	0.00419	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PGLS—osteoporosis	0.000609	0.00419	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000599	0.00412	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA2—osteoporosis	0.000593	0.00408	CbGpPWpGaD
Capecitabine—CDA—Metabolism—OXCT1—osteoporosis	0.000593	0.00408	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000587	0.00404	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MGLL—osteoporosis	0.000578	0.00398	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—osteoporosis	0.000576	0.00397	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ATIC—osteoporosis	0.000557	0.00384	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PNP—osteoporosis	0.000557	0.00384	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—IDH2—osteoporosis	0.000551	0.00379	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000535	0.00368	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP27A1—osteoporosis	0.000518	0.00357	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ACP5—osteoporosis	0.000504	0.00347	CbGpPWpGaD
Capecitabine—CDA—Metabolism—IDH2—osteoporosis	0.000491	0.00338	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA2—osteoporosis	0.000474	0.00326	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—OXCT1—osteoporosis	0.000474	0.00326	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TPI1—osteoporosis	0.000469	0.00322	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP27A1—osteoporosis	0.000462	0.00318	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MGLL—osteoporosis	0.000462	0.00318	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ACP5—osteoporosis	0.000449	0.00309	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—P4HB—osteoporosis	0.000441	0.00303	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GAPDH—osteoporosis	0.000432	0.00298	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—RAP1A—osteoporosis	0.000421	0.0029	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TPI1—osteoporosis	0.000418	0.00287	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—osteoporosis	0.0004	0.00275	CbGpPWpGaD
Capecitabine—CDA—Metabolism—P4HB—osteoporosis	0.000393	0.0027	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—IDH2—osteoporosis	0.000393	0.0027	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000388	0.00267	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GAPDH—osteoporosis	0.000385	0.00265	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000383	0.00264	CbGpPWpGaD
Capecitabine—CDA—Metabolism—RAP1A—osteoporosis	0.000375	0.00258	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP27A1—osteoporosis	0.000369	0.00254	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000366	0.00252	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ACP5—osteoporosis	0.000359	0.00247	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.000358	0.00247	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000356	0.00245	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000348	0.00239	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ENO1—osteoporosis	0.00034	0.00234	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PSMA5—osteoporosis	0.000335	0.00231	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PSMA2—osteoporosis	0.000335	0.00231	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TPI1—osteoporosis	0.000334	0.0023	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB1—osteoporosis	0.00033	0.00227	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FDPS—osteoporosis	0.000329	0.00226	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PKM—osteoporosis	0.000329	0.00226	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000318	0.00219	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000318	0.00219	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000318	0.00219	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000315	0.00217	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000314	0.00216	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—P4HB—osteoporosis	0.000314	0.00216	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPD2—osteoporosis	0.000312	0.00215	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PGLS—osteoporosis	0.000312	0.00215	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000308	0.00212	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GAPDH—osteoporosis	0.000308	0.00212	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ENO1—osteoporosis	0.000303	0.00209	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—RAP1A—osteoporosis	0.0003	0.00207	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PSMA2—osteoporosis	0.000299	0.00206	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PSMA5—osteoporosis	0.000299	0.00206	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—osteoporosis	0.00029	0.002	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ATIC—osteoporosis	0.000285	0.00196	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PNP—osteoporosis	0.000285	0.00196	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000285	0.00196	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000285	0.00196	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP19A1—osteoporosis	0.000272	0.00187	CbGpPWpGaD
Capecitabine—Pruritus—Estropipate—osteoporosis	0.000246	0.000344	CcSEcCtD
Capecitabine—Discomfort—Zoledronate—osteoporosis	0.000246	0.000344	CcSEcCtD
Capecitabine—Asthenia—Alendronate—osteoporosis	0.000246	0.000344	CcSEcCtD
Capecitabine—Hypersensitivity—Ibandronate—osteoporosis	0.000246	0.000344	CcSEcCtD
Capecitabine—Cough—Conjugated Estrogens—osteoporosis	0.000246	0.000344	CcSEcCtD
Capecitabine—Dyspnoea—Risedronate—osteoporosis	0.000245	0.000343	CcSEcCtD
Capecitabine—Erythema multiforme—Estradiol—osteoporosis	0.000245	0.000342	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000245	0.00168	CbGpPWpGaD
Capecitabine—Hypotension—Pamidronate—osteoporosis	0.000244	0.000342	CcSEcCtD
Capecitabine—Dry mouth—Zoledronate—osteoporosis	0.000243	0.000341	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000243	0.00034	CcSEcCtD
Capecitabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000243	0.00034	CcSEcCtD
Capecitabine—CDA—Metabolism—CYP19A1—osteoporosis	0.000243	0.00167	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ENO1—osteoporosis	0.000243	0.00167	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CA2—osteoporosis	0.000242	0.00167	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—OXCT1—osteoporosis	0.000242	0.00167	CbGpPWpGaD
Capecitabine—Pruritus—Alendronate—osteoporosis	0.000242	0.000339	CcSEcCtD
Capecitabine—Dyspepsia—Risedronate—osteoporosis	0.000242	0.000338	CcSEcCtD
Capecitabine—Eye disorder—Estradiol—osteoporosis	0.000242	0.000338	CcSEcCtD
Capecitabine—Tinnitus—Estradiol—osteoporosis	0.000241	0.000338	CcSEcCtD
Capecitabine—Constipation—Ethinyl Estradiol—osteoporosis	0.000241	0.000337	CcSEcCtD
Capecitabine—Confusional state—Zoledronate—osteoporosis	0.000241	0.000337	CcSEcCtD
Capecitabine—Hypersensitivity—Calcitriol—osteoporosis	0.000241	0.000336	CcSEcCtD
Capecitabine—Cardiac disorder—Estradiol—osteoporosis	0.00024	0.000336	CcSEcCtD
Capecitabine—Flushing—Estradiol—osteoporosis	0.00024	0.000336	CcSEcCtD
Capecitabine—Myalgia—Conjugated Estrogens—osteoporosis	0.00024	0.000335	CcSEcCtD
Capecitabine—Chest pain—Conjugated Estrogens—osteoporosis	0.00024	0.000335	CcSEcCtD
Capecitabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00024	0.000335	CcSEcCtD
Capecitabine—Asthenia—Ibandronate—osteoporosis	0.000239	0.000335	CcSEcCtD
Capecitabine—TYMP—Metabolism—PSMA5—osteoporosis	0.000239	0.00164	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PSMA2—osteoporosis	0.000239	0.00164	CbGpPWpGaD
Capecitabine—Anxiety—Conjugated Estrogens—osteoporosis	0.000239	0.000334	CcSEcCtD
Capecitabine—Nausea—Etidronic acid—osteoporosis	0.000239	0.000334	CcSEcCtD
Capecitabine—Oedema—Zoledronate—osteoporosis	0.000239	0.000334	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000238	0.000333	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000238	0.000333	CcSEcCtD
Capecitabine—Diarrhoea—Estropipate—osteoporosis	0.000238	0.000333	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000237	0.000332	CcSEcCtD
Capecitabine—Infection—Zoledronate—osteoporosis	0.000237	0.000332	CcSEcCtD
Capecitabine—Fatigue—Risedronate—osteoporosis	0.000237	0.000331	CcSEcCtD
Capecitabine—Insomnia—Pamidronate—osteoporosis	0.000236	0.000331	CcSEcCtD
Capecitabine—TYMS—Metabolism—MGLL—osteoporosis	0.000236	0.00163	CbGpPWpGaD
Capecitabine—Pruritus—Ibandronate—osteoporosis	0.000236	0.00033	CcSEcCtD
Capecitabine—Constipation—Risedronate—osteoporosis	0.000235	0.000329	CcSEcCtD
Capecitabine—Pain—Risedronate—osteoporosis	0.000235	0.000329	CcSEcCtD
Capecitabine—Angiopathy—Estradiol—osteoporosis	0.000235	0.000329	CcSEcCtD
Capecitabine—Shock—Zoledronate—osteoporosis	0.000235	0.000328	CcSEcCtD
Capecitabine—Paraesthesia—Pamidronate—osteoporosis	0.000235	0.000328	CcSEcCtD
Capecitabine—Diarrhoea—Alendronate—osteoporosis	0.000234	0.000328	CcSEcCtD
Capecitabine—Asthenia—Calcitriol—osteoporosis	0.000234	0.000328	CcSEcCtD
Capecitabine—Nervous system disorder—Zoledronate—osteoporosis	0.000234	0.000327	CcSEcCtD
Capecitabine—Immune system disorder—Estradiol—osteoporosis	0.000234	0.000327	CcSEcCtD
Capecitabine—Thrombocytopenia—Zoledronate—osteoporosis	0.000234	0.000327	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000233	0.00161	CbGpPWpGaD
Capecitabine—Mediastinal disorder—Estradiol—osteoporosis	0.000233	0.000326	CcSEcCtD
Capecitabine—Dyspnoea—Pamidronate—osteoporosis	0.000233	0.000326	CcSEcCtD
Capecitabine—Tachycardia—Zoledronate—osteoporosis	0.000233	0.000326	CcSEcCtD
Capecitabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000232	0.000325	CcSEcCtD
Capecitabine—Chills—Estradiol—osteoporosis	0.000232	0.000325	CcSEcCtD
Capecitabine—Skin disorder—Zoledronate—osteoporosis	0.000232	0.000324	CcSEcCtD
Capecitabine—Pruritus—Calcitriol—osteoporosis	0.000231	0.000323	CcSEcCtD
Capecitabine—Hyperhidrosis—Zoledronate—osteoporosis	0.000231	0.000323	CcSEcCtD
Capecitabine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000231	0.000322	CcSEcCtD
Capecitabine—Diarrhoea—Raloxifene—osteoporosis	0.000231	0.000322	CcSEcCtD
Capecitabine—Dyspepsia—Pamidronate—osteoporosis	0.00023	0.000322	CcSEcCtD
Capecitabine—Dizziness—Estropipate—osteoporosis	0.00023	0.000322	CcSEcCtD
Capecitabine—Oedema—Conjugated Estrogens—osteoporosis	0.00023	0.000321	CcSEcCtD
Capecitabine—Alopecia—Estradiol—osteoporosis	0.000229	0.00032	CcSEcCtD
Capecitabine—Infection—Conjugated Estrogens—osteoporosis	0.000228	0.000319	CcSEcCtD
Capecitabine—Diarrhoea—Ibandronate—osteoporosis	0.000228	0.000319	CcSEcCtD
Capecitabine—Anorexia—Zoledronate—osteoporosis	0.000228	0.000318	CcSEcCtD
Capecitabine—Decreased appetite—Pamidronate—osteoporosis	0.000227	0.000318	CcSEcCtD
Capecitabine—Mental disorder—Estradiol—osteoporosis	0.000227	0.000317	CcSEcCtD
Capecitabine—Dizziness—Alendronate—osteoporosis	0.000227	0.000317	CcSEcCtD
Capecitabine—Shock—Conjugated Estrogens—osteoporosis	0.000226	0.000316	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000226	0.000316	CcSEcCtD
Capecitabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000225	0.000315	CcSEcCtD
Capecitabine—Erythema—Estradiol—osteoporosis	0.000225	0.000315	CcSEcCtD
Capecitabine—Malnutrition—Estradiol—osteoporosis	0.000225	0.000315	CcSEcCtD
Capecitabine—Fatigue—Pamidronate—osteoporosis	0.000225	0.000315	CcSEcCtD
Capecitabine—Gastrointestinal pain—Risedronate—osteoporosis	0.000225	0.000314	CcSEcCtD
Capecitabine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000224	0.000314	CcSEcCtD
Capecitabine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000224	0.000313	CcSEcCtD
Capecitabine—Constipation—Pamidronate—osteoporosis	0.000223	0.000313	CcSEcCtD
Capecitabine—Pain—Pamidronate—osteoporosis	0.000223	0.000313	CcSEcCtD
Capecitabine—Diarrhoea—Calcitriol—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—Hypotension—Zoledronate—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—Dizziness—Raloxifene—osteoporosis	0.000223	0.000312	CcSEcCtD
Capecitabine—DPYD—Metabolism—ADCY5—osteoporosis	0.000222	0.00153	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000222	0.000311	CcSEcCtD
Capecitabine—Flatulence—Estradiol—osteoporosis	0.000222	0.000311	CcSEcCtD
Capecitabine—DPYD—Metabolism—GPX1—osteoporosis	0.000222	0.00153	CbGpPWpGaD
Capecitabine—Vomiting—Estropipate—osteoporosis	0.000221	0.000309	CcSEcCtD
Capecitabine—Dysgeusia—Estradiol—osteoporosis	0.000221	0.000309	CcSEcCtD
Capecitabine—Dizziness—Ibandronate—osteoporosis	0.000221	0.000309	CcSEcCtD
Capecitabine—Rash—Estropipate—osteoporosis	0.000219	0.000307	CcSEcCtD
Capecitabine—Dermatitis—Estropipate—osteoporosis	0.000219	0.000306	CcSEcCtD
Capecitabine—Anorexia—Conjugated Estrogens—osteoporosis	0.000219	0.000306	CcSEcCtD
Capecitabine—Urticaria—Risedronate—osteoporosis	0.000218	0.000305	CcSEcCtD
Capecitabine—Back pain—Estradiol—osteoporosis	0.000218	0.000305	CcSEcCtD
Capecitabine—Headache—Estropipate—osteoporosis	0.000218	0.000305	CcSEcCtD
Capecitabine—Vomiting—Alendronate—osteoporosis	0.000218	0.000305	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000217	0.000304	CcSEcCtD
Capecitabine—Abdominal pain—Risedronate—osteoporosis	0.000217	0.000304	CcSEcCtD
Capecitabine—Body temperature increased—Risedronate—osteoporosis	0.000217	0.000304	CcSEcCtD
Capecitabine—Muscle spasms—Estradiol—osteoporosis	0.000217	0.000303	CcSEcCtD
Capecitabine—Rash—Alendronate—osteoporosis	0.000216	0.000302	CcSEcCtD
Capecitabine—Insomnia—Zoledronate—osteoporosis	0.000216	0.000302	CcSEcCtD
Capecitabine—Dermatitis—Alendronate—osteoporosis	0.000216	0.000302	CcSEcCtD
Capecitabine—Feeling abnormal—Pamidronate—osteoporosis	0.000215	0.000301	CcSEcCtD
Capecitabine—Hypotension—Conjugated Estrogens—osteoporosis	0.000215	0.0003	CcSEcCtD
Capecitabine—Headache—Alendronate—osteoporosis	0.000215	0.0003	CcSEcCtD
Capecitabine—Paraesthesia—Zoledronate—osteoporosis	0.000214	0.0003	CcSEcCtD
Capecitabine—Vomiting—Raloxifene—osteoporosis	0.000214	0.0003	CcSEcCtD
Capecitabine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000214	0.000299	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000213	0.00146	CbGpPWpGaD
Capecitabine—Dyspnoea—Zoledronate—osteoporosis	0.000213	0.000298	CcSEcCtD
Capecitabine—Rash—Raloxifene—osteoporosis	0.000212	0.000297	CcSEcCtD
Capecitabine—Dermatitis—Raloxifene—osteoporosis	0.000212	0.000297	CcSEcCtD
Capecitabine—Vomiting—Ibandronate—osteoporosis	0.000212	0.000297	CcSEcCtD
Capecitabine—Tremor—Estradiol—osteoporosis	0.000211	0.000295	CcSEcCtD
Capecitabine—Headache—Raloxifene—osteoporosis	0.000211	0.000295	CcSEcCtD
Capecitabine—Rash—Ibandronate—osteoporosis	0.00021	0.000294	CcSEcCtD
Capecitabine—Dermatitis—Ibandronate—osteoporosis	0.00021	0.000294	CcSEcCtD
Capecitabine—Dyspepsia—Zoledronate—osteoporosis	0.00021	0.000294	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000209	0.000293	CcSEcCtD
Capecitabine—Ill-defined disorder—Estradiol—osteoporosis	0.000209	0.000292	CcSEcCtD
Capecitabine—Headache—Ibandronate—osteoporosis	0.000209	0.000292	CcSEcCtD
Capecitabine—Insomnia—Conjugated Estrogens—osteoporosis	0.000208	0.000291	CcSEcCtD
Capecitabine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000208	0.000291	CcSEcCtD
Capecitabine—Vomiting—Calcitriol—osteoporosis	0.000208	0.00029	CcSEcCtD
Capecitabine—Decreased appetite—Zoledronate—osteoporosis	0.000207	0.00029	CcSEcCtD
Capecitabine—Nausea—Estropipate—osteoporosis	0.000207	0.000289	CcSEcCtD
Capecitabine—Body temperature increased—Pamidronate—osteoporosis	0.000207	0.000289	CcSEcCtD
Capecitabine—Abdominal pain—Pamidronate—osteoporosis	0.000207	0.000289	CcSEcCtD
Capecitabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000206	0.000289	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000206	0.000288	CcSEcCtD
Capecitabine—Rash—Calcitriol—osteoporosis	0.000206	0.000288	CcSEcCtD
Capecitabine—Fatigue—Zoledronate—osteoporosis	0.000206	0.000288	CcSEcCtD
Capecitabine—Dermatitis—Calcitriol—osteoporosis	0.000206	0.000288	CcSEcCtD
Capecitabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000205	0.000287	CcSEcCtD
Capecitabine—Headache—Calcitriol—osteoporosis	0.000205	0.000286	CcSEcCtD
Capecitabine—DPYD—Metabolism—MTHFR—osteoporosis	0.000205	0.00141	CbGpPWpGaD
Capecitabine—Constipation—Zoledronate—osteoporosis	0.000204	0.000285	CcSEcCtD
Capecitabine—Pain—Zoledronate—osteoporosis	0.000204	0.000285	CcSEcCtD
Capecitabine—Nausea—Alendronate—osteoporosis	0.000203	0.000285	CcSEcCtD
Capecitabine—Malaise—Estradiol—osteoporosis	0.000203	0.000284	CcSEcCtD
Capecitabine—Hypersensitivity—Risedronate—osteoporosis	0.000203	0.000283	CcSEcCtD
Capecitabine—Vertigo—Estradiol—osteoporosis	0.000202	0.000283	CcSEcCtD
Capecitabine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000202	0.000283	CcSEcCtD
Capecitabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000202	0.000283	CcSEcCtD
Capecitabine—Syncope—Estradiol—osteoporosis	0.000202	0.000283	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000202	0.00139	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH2—osteoporosis	0.000201	0.00138	CbGpPWpGaD
Capecitabine—Nausea—Raloxifene—osteoporosis	0.0002	0.00028	CcSEcCtD
Capecitabine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.0002	0.000279	CcSEcCtD
Capecitabine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000199	0.000279	CcSEcCtD
Capecitabine—Palpitations—Estradiol—osteoporosis	0.000199	0.000279	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000198	0.000278	CcSEcCtD
Capecitabine—CDA—Metabolism—ADCY5—osteoporosis	0.000198	0.00136	CbGpPWpGaD
Capecitabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000198	0.000277	CcSEcCtD
Capecitabine—Nausea—Ibandronate—osteoporosis	0.000198	0.000277	CcSEcCtD
Capecitabine—Loss of consciousness—Estradiol—osteoporosis	0.000198	0.000277	CcSEcCtD
Capecitabine—CDA—Metabolism—GPX1—osteoporosis	0.000198	0.00136	CbGpPWpGaD
Capecitabine—Asthenia—Risedronate—osteoporosis	0.000197	0.000276	CcSEcCtD
Capecitabine—Feeling abnormal—Zoledronate—osteoporosis	0.000197	0.000275	CcSEcCtD
Capecitabine—Cough—Estradiol—osteoporosis	0.000197	0.000275	CcSEcCtD
Capecitabine—Constipation—Conjugated Estrogens—osteoporosis	0.000197	0.000275	CcSEcCtD
Capecitabine—Pain—Conjugated Estrogens—osteoporosis	0.000197	0.000275	CcSEcCtD
Capecitabine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000195	0.000273	CcSEcCtD
Capecitabine—Hypertension—Estradiol—osteoporosis	0.000195	0.000272	CcSEcCtD
Capecitabine—Pruritus—Risedronate—osteoporosis	0.000194	0.000272	CcSEcCtD
Capecitabine—Nausea—Calcitriol—osteoporosis	0.000194	0.000271	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYP19A1—osteoporosis	0.000194	0.00133	CbGpPWpGaD
Capecitabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000193	0.00027	CcSEcCtD
Capecitabine—Hypersensitivity—Pamidronate—osteoporosis	0.000193	0.000269	CcSEcCtD
Capecitabine—Myalgia—Estradiol—osteoporosis	0.000192	0.000268	CcSEcCtD
Capecitabine—Arthralgia—Estradiol—osteoporosis	0.000192	0.000268	CcSEcCtD
Capecitabine—Chest pain—Estradiol—osteoporosis	0.000192	0.000268	CcSEcCtD
Capecitabine—Anxiety—Estradiol—osteoporosis	0.000191	0.000267	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000191	0.000267	CcSEcCtD
Capecitabine—Urticaria—Zoledronate—osteoporosis	0.00019	0.000265	CcSEcCtD
Capecitabine—Discomfort—Estradiol—osteoporosis	0.00019	0.000265	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000189	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP27A1—osteoporosis	0.000189	0.0013	CbGpPWpGaD
Capecitabine—Abdominal pain—Zoledronate—osteoporosis	0.000189	0.000264	CcSEcCtD
Capecitabine—Body temperature increased—Zoledronate—osteoporosis	0.000189	0.000264	CcSEcCtD
Capecitabine—Diarrhoea—Risedronate—osteoporosis	0.000188	0.000263	CcSEcCtD
Capecitabine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000188	0.000263	CcSEcCtD
Capecitabine—Dry mouth—Estradiol—osteoporosis	0.000188	0.000262	CcSEcCtD
Capecitabine—Asthenia—Pamidronate—osteoporosis	0.000187	0.000262	CcSEcCtD
Capecitabine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000186	0.000261	CcSEcCtD
Capecitabine—Confusional state—Estradiol—osteoporosis	0.000185	0.000259	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000185	0.00128	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000185	0.00127	CbGpPWpGaD
Capecitabine—Pruritus—Pamidronate—osteoporosis	0.000185	0.000259	CcSEcCtD
Capecitabine—Oedema—Estradiol—osteoporosis	0.000184	0.000257	CcSEcCtD
Capecitabine—TYMS—Metabolism—ACP5—osteoporosis	0.000184	0.00126	CbGpPWpGaD
Capecitabine—Infection—Estradiol—osteoporosis	0.000183	0.000256	CcSEcCtD
Capecitabine—Urticaria—Conjugated Estrogens—osteoporosis	0.000183	0.000255	CcSEcCtD
Capecitabine—CDA—Metabolism—MTHFR—osteoporosis	0.000182	0.00125	CbGpPWpGaD
Capecitabine—Dizziness—Risedronate—osteoporosis	0.000182	0.000254	CcSEcCtD
Capecitabine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000182	0.000254	CcSEcCtD
Capecitabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000182	0.000254	CcSEcCtD
Capecitabine—Shock—Estradiol—osteoporosis	0.000181	0.000253	CcSEcCtD
Capecitabine—Nervous system disorder—Estradiol—osteoporosis	0.00018	0.000252	CcSEcCtD
Capecitabine—Tachycardia—Estradiol—osteoporosis	0.00018	0.000251	CcSEcCtD
Capecitabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000179	0.000251	CcSEcCtD
Capecitabine—Diarrhoea—Pamidronate—osteoporosis	0.000179	0.00025	CcSEcCtD
Capecitabine—Skin disorder—Estradiol—osteoporosis	0.000179	0.00025	CcSEcCtD
Capecitabine—Hyperhidrosis—Estradiol—osteoporosis	0.000178	0.000249	CcSEcCtD
Capecitabine—Rash—Ethinyl Estradiol—osteoporosis	0.000178	0.000249	CcSEcCtD
Capecitabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000178	0.000248	CcSEcCtD
Capecitabine—Headache—Ethinyl Estradiol—osteoporosis	0.000177	0.000247	CcSEcCtD
Capecitabine—Hypersensitivity—Zoledronate—osteoporosis	0.000176	0.000246	CcSEcCtD
Capecitabine—Vomiting—Risedronate—osteoporosis	0.000175	0.000244	CcSEcCtD
Capecitabine—Rash—Risedronate—osteoporosis	0.000173	0.000242	CcSEcCtD
Capecitabine—Dermatitis—Risedronate—osteoporosis	0.000173	0.000242	CcSEcCtD
Capecitabine—Dizziness—Pamidronate—osteoporosis	0.000173	0.000242	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000173	0.00119	CbGpPWpGaD
Capecitabine—Headache—Risedronate—osteoporosis	0.000172	0.000241	CcSEcCtD
Capecitabine—Asthenia—Zoledronate—osteoporosis	0.000171	0.00024	CcSEcCtD
Capecitabine—TYMS—Metabolism—TPI1—osteoporosis	0.000171	0.00118	CbGpPWpGaD
Capecitabine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000169	0.000237	CcSEcCtD
Capecitabine—Pruritus—Zoledronate—osteoporosis	0.000169	0.000236	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000168	0.000234	CcSEcCtD
Capecitabine—Nausea—Ethinyl Estradiol—osteoporosis	0.000167	0.000234	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	0.000167	0.00115	CbGpPWpGaD
Capecitabine—Insomnia—Estradiol—osteoporosis	0.000166	0.000233	CcSEcCtD
Capecitabine—Vomiting—Pamidronate—osteoporosis	0.000166	0.000232	CcSEcCtD
Capecitabine—Paraesthesia—Estradiol—osteoporosis	0.000165	0.000231	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000165	0.00113	CbGpPWpGaD
Capecitabine—Asthenia—Conjugated Estrogens—osteoporosis	0.000165	0.000231	CcSEcCtD
Capecitabine—Rash—Pamidronate—osteoporosis	0.000165	0.00023	CcSEcCtD
Capecitabine—Dermatitis—Pamidronate—osteoporosis	0.000165	0.00023	CcSEcCtD
Capecitabine—Dyspnoea—Estradiol—osteoporosis	0.000164	0.000229	CcSEcCtD
Capecitabine—Headache—Pamidronate—osteoporosis	0.000164	0.000229	CcSEcCtD
Capecitabine—DPYD—Metabolism—POMC—osteoporosis	0.000164	0.00113	CbGpPWpGaD
Capecitabine—Diarrhoea—Zoledronate—osteoporosis	0.000163	0.000228	CcSEcCtD
Capecitabine—Nausea—Risedronate—osteoporosis	0.000163	0.000228	CcSEcCtD
Capecitabine—Pruritus—Conjugated Estrogens—osteoporosis	0.000163	0.000227	CcSEcCtD
Capecitabine—Dyspepsia—Estradiol—osteoporosis	0.000162	0.000226	CcSEcCtD
Capecitabine—TYMS—Metabolism—P4HB—osteoporosis	0.000161	0.00111	CbGpPWpGaD
Capecitabine—Decreased appetite—Estradiol—osteoporosis	0.00016	0.000224	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000159	0.000222	CcSEcCtD
Capecitabine—Fatigue—Estradiol—osteoporosis	0.000159	0.000222	CcSEcCtD
Capecitabine—TYMP—Metabolism—ADCY5—osteoporosis	0.000158	0.00109	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPX1—osteoporosis	0.000158	0.00109	CbGpPWpGaD
Capecitabine—Dizziness—Zoledronate—osteoporosis	0.000158	0.000221	CcSEcCtD
Capecitabine—TYMS—Metabolism—GAPDH—osteoporosis	0.000158	0.00108	CbGpPWpGaD
Capecitabine—Pain—Estradiol—osteoporosis	0.000157	0.00022	CcSEcCtD
Capecitabine—Constipation—Estradiol—osteoporosis	0.000157	0.00022	CcSEcCtD
Capecitabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000157	0.00022	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000157	0.00108	CbGpPWpGaD
Capecitabine—Nausea—Pamidronate—osteoporosis	0.000155	0.000217	CcSEcCtD
Capecitabine—TYMS—Metabolism—RAP1A—osteoporosis	0.000154	0.00106	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000153	0.00105	CbGpPWpGaD
Capecitabine—Dizziness—Conjugated Estrogens—osteoporosis	0.000152	0.000213	CcSEcCtD
Capecitabine—Vomiting—Zoledronate—osteoporosis	0.000152	0.000212	CcSEcCtD
Capecitabine—Feeling abnormal—Estradiol—osteoporosis	0.000152	0.000212	CcSEcCtD
Capecitabine—Rash—Zoledronate—osteoporosis	0.00015	0.000211	CcSEcCtD
Capecitabine—Gastrointestinal pain—Estradiol—osteoporosis	0.00015	0.00021	CcSEcCtD
Capecitabine—Dermatitis—Zoledronate—osteoporosis	0.00015	0.00021	CcSEcCtD
Capecitabine—Headache—Zoledronate—osteoporosis	0.00015	0.000209	CcSEcCtD
Capecitabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000146	0.000204	CcSEcCtD
Capecitabine—Urticaria—Estradiol—osteoporosis	0.000146	0.000204	CcSEcCtD
Capecitabine—CDA—Metabolism—POMC—osteoporosis	0.000146	0.001	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—osteoporosis	0.000146	0.001	CbGpPWpGaD
Capecitabine—Abdominal pain—Estradiol—osteoporosis	0.000145	0.000203	CcSEcCtD
Capecitabine—Body temperature increased—Estradiol—osteoporosis	0.000145	0.000203	CcSEcCtD
Capecitabine—Rash—Conjugated Estrogens—osteoporosis	0.000145	0.000203	CcSEcCtD
Capecitabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000145	0.000203	CcSEcCtD
Capecitabine—Headache—Conjugated Estrogens—osteoporosis	0.000144	0.000201	CcSEcCtD
Capecitabine—Nausea—Zoledronate—osteoporosis	0.000142	0.000198	CcSEcCtD
Capecitabine—Nausea—Conjugated Estrogens—osteoporosis	0.000137	0.000191	CcSEcCtD
Capecitabine—Hypersensitivity—Estradiol—osteoporosis	0.000136	0.00019	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—IL6—osteoporosis	0.000134	0.00092	CbGpPWpGaD
Capecitabine—Asthenia—Estradiol—osteoporosis	0.000132	0.000185	CcSEcCtD
Capecitabine—Pruritus—Estradiol—osteoporosis	0.00013	0.000182	CcSEcCtD
Capecitabine—Diarrhoea—Estradiol—osteoporosis	0.000126	0.000176	CcSEcCtD
Capecitabine—TYMS—Metabolism—ENO1—osteoporosis	0.000124	0.000854	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMA2—osteoporosis	0.000122	0.000841	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PSMA5—osteoporosis	0.000122	0.000841	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000122	0.000841	CbGpPWpGaD
Capecitabine—Dizziness—Estradiol—osteoporosis	0.000122	0.00017	CcSEcCtD
Capecitabine—Vomiting—Estradiol—osteoporosis	0.000117	0.000164	CcSEcCtD
Capecitabine—TYMP—Metabolism—POMC—osteoporosis	0.000117	0.000802	CbGpPWpGaD
Capecitabine—Rash—Estradiol—osteoporosis	0.000116	0.000162	CcSEcCtD
Capecitabine—Dermatitis—Estradiol—osteoporosis	0.000116	0.000162	CcSEcCtD
Capecitabine—Headache—Estradiol—osteoporosis	0.000115	0.000161	CcSEcCtD
Capecitabine—Nausea—Estradiol—osteoporosis	0.000109	0.000153	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000104	0.000715	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—POMC—osteoporosis	0.0001	0.000692	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP19A1—osteoporosis	9.92e-05	0.000683	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FDPS—osteoporosis	9.48e-05	0.000652	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PKM—osteoporosis	9.48e-05	0.000652	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPD2—osteoporosis	8.98e-05	0.000618	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PGLS—osteoporosis	8.98e-05	0.000618	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	8.97e-05	0.000617	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ATIC—osteoporosis	8.22e-05	0.000566	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PNP—osteoporosis	8.22e-05	0.000566	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ADCY5—osteoporosis	8.11e-05	0.000558	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—osteoporosis	8.08e-05	0.000556	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—osteoporosis	8.02e-05	0.000552	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—osteoporosis	7.45e-05	0.000513	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—OXCT1—osteoporosis	6.99e-05	0.000481	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA2—osteoporosis	6.99e-05	0.000481	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MGLL—osteoporosis	6.81e-05	0.000469	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.42e-05	0.000442	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—POMC—osteoporosis	5.96e-05	0.00041	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—IDH2—osteoporosis	5.79e-05	0.000398	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP27A1—osteoporosis	5.44e-05	0.000375	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACP5—osteoporosis	5.3e-05	0.000364	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.23e-05	0.00036	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TPI1—osteoporosis	4.92e-05	0.000339	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—P4HB—osteoporosis	4.63e-05	0.000319	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GAPDH—osteoporosis	4.54e-05	0.000313	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—RAP1A—osteoporosis	4.42e-05	0.000305	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.86e-05	0.000266	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO1—osteoporosis	3.58e-05	0.000246	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMA5—osteoporosis	3.52e-05	0.000243	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PSMA2—osteoporosis	3.52e-05	0.000243	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.86e-05	0.000197	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADCY5—osteoporosis	2.34e-05	0.000161	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—osteoporosis	2.33e-05	0.00016	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—osteoporosis	2.15e-05	0.000148	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—osteoporosis	1.72e-05	0.000118	CbGpPWpGaD
